tiprankstipranks
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders StocksMarket MoversTipRanks 50 IndexAI StocksLargest Companies by Market Cap
ETFs
Top ETFs by UpsideTop ETFs by Smart ScoreTop Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Research Tools
Trending StocksCompare StocksCompare ETFsTrump Dashboard
New
Daily Feeds
Daily Analyst RatingsDaily Insider Trading Tracker
Calendars
Earnings CalendarDividend CalendarEconomic CalendarIPO CalendarStock SplitsStock BuybacksFDA CalendarMarket Holidays
Calculators
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Economic Indicators
Inflation RateUnemployment Rate
Class Actions
Stock ScreenerETF Screener
Popular
Penny Stock ScreenerTechnical Analysis Screener
Dividend CenterBest Dividend Stocks
Popular
Best High Yield Dividend StocksDividend AristocratsDividend Stock Comparison
New
Dividend CalculatorDividend Returns ComparisonDividend Calendar
My ExpertsTop AnalystsTop Financial BloggersTop-Performing Corporate InsidersTop Hedge Fund ManagersTop Research FirmsTop Individual Investors
Trending News
More News >
Education
Personal FinanceHow To Use TipRanksTipRanks LabsGlossaryFAQs
About Us
About TipRanksContact UsReviewsMobile APP
Working with TipRanks
Enterprise SolutionsAdvertise with UsTop Online BrokersBecome an AffiliateTipRanks News Wire
Follow Us
TOOLS
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Market Movers
Compare stocks
Compare ETFs
Notification Center
News
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders Stocks
Compare Stocks
Compare ETFs
Trending Stocks
Daily Analyst Ratings
Daily Insiders Trades
Dividend Stocks
ETF Center
Top Gainers/losers/active ETFs
Trump Dashboard
New
Dividend Calculator
Options Profit Calculator
Dollar Cost Averaging
Compound Interest Calculator
Mortgage Calculator
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
FDA Calendar
Market Holidays
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Top Gainers
Top Losers
Most Active
Premarket
After-hours
Private Companies
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Real Estate
Top Online Brokers
Enterprise Solutions
Plans & Pricing
Education
How To Use TipRanks
TipRanks Labs
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us
STOCKS
SPY
QQQ
AAPL
NVDA
TSLA
AMZN
BABA
Advertisement
Advertisement

INCY Stock Latest News

Qualcomm, Adobe downgraded: Wall Street’s top analyst calls
The FlyQualcomm, Adobe downgraded: Wall Street’s top analyst calls
15h ago
ECL
ETN
Incyte downgraded to Hold from Buy at Jefferies
PremiumThe Fly
Incyte downgraded to Hold from Buy at Jefferies
19h ago
INCY
Incyte Advances New Early Stage Drug INCA033989 Into Human Testing
PremiumCompany Announcements
Incyte Advances New Early Stage Drug INCA033989 Into Human Testing
6d ago
INCY
Incyte’s Ruxolitinib Pediatric Leukemia Study Update: What Investors Should Watch
PremiumCompany Announcements
Incyte’s Ruxolitinib Pediatric Leukemia Study Update: What Investors Should Watch
6d ago
INCY
Balancing Post‑Jakafi Opportunities and Execution Risks: Rationale Behind a Neutral Stance on Incyte
PremiumRatings
Balancing Post‑Jakafi Opportunities and Execution Risks: Rationale Behind a Neutral Stance on Incyte
10d ago
INCY
Incyte Faces FDA Setback on Zynyz Lung Cancer Expansion
PremiumCompany AnnouncementsIncyte Faces FDA Setback on Zynyz Lung Cancer Expansion
10d ago
8K
INCY
Incyte announces European Commission approval of Zynyz
Premium
The Fly
Incyte announces European Commission approval of Zynyz
10d ago
INCY
Eli Lilly, Incyte: EMA’s CHMP issues positive opinion for Olumiant
Premium
The Fly
Eli Lilly, Incyte: EMA’s CHMP issues positive opinion for Olumiant
18d ago
LLY
INCY
Knight Therapeutics announces NIKTIMVO regulatory submission in Brazil
PremiumThe Fly
Knight Therapeutics announces NIKTIMVO regulatory submission in Brazil
27d ago
INCY
Incyte price target raised to $117 from $116 at Barclays
PremiumThe Fly
Incyte price target raised to $117 from $116 at Barclays
27d ago
INCY
Incyte’s Profit Outlook Threatened by Emerging U.S. ‘Most Favored Nation’ Drug Pricing Policies
PremiumCompany Announcements
Incyte’s Profit Outlook Threatened by Emerging U.S. ‘Most Favored Nation’ Drug Pricing Policies
1M ago
INCY
Incyte price target raised to $102 from $94 at Morgan Stanley
PremiumThe Fly
Incyte price target raised to $102 from $94 at Morgan Stanley
1M ago
INCY
Incyte price target raised to $120 from $119 at Stifel
PremiumThe FlyIncyte price target raised to $120 from $119 at Stifel
1M ago
INCY
Incyte: Long-Term Revenue Durability and Underappreciated Pipeline Support Buy Rating and $135 Target
Premium
Ratings
Incyte: Long-Term Revenue Durability and Underappreciated Pipeline Support Buy Rating and $135 Target
1M ago
INCY
Incyte Earnings Call Highlights Growth Beyond Jakafi
Premium
Company Announcements
Incyte Earnings Call Highlights Growth Beyond Jakafi
1M ago
INCY
Morning Movers: Fiserv and Spotify jump following fourth quarter results
PremiumThe Fly
Morning Movers: Fiserv and Spotify jump following fourth quarter results
1M ago
KO
ON
Incyte sees FY26 product revenue $4.77B-$4.94B
PremiumThe Fly
Incyte sees FY26 product revenue $4.77B-$4.94B
1M ago
INCY
Incyte reports Q4 EPS $1.80, consensus $1.92
PremiumThe Fly
Incyte reports Q4 EPS $1.80, consensus $1.92
1M ago
INCY
Notable companies reporting before tomorrow’s open
PremiumThe Fly
Notable companies reporting before tomorrow’s open
1M ago
KO
CVS
INCY Earnings Report this Week: Is It a Buy, Ahead of Earnings?
PremiumPre-EarningsINCY Earnings Report this Week: Is It a Buy, Ahead of Earnings?
1M ago
INCY
Incyte price target raised to $110 from $102 at Piper Sandler
Premium
The Fly
Incyte price target raised to $110 from $102 at Piper Sandler
1M ago
INCY
Microsoft downgraded, Snap upgraded: Wall Street’s top analyst calls
Premium
The Fly
Microsoft downgraded, Snap upgraded: Wall Street’s top analyst calls
1M ago
CE
ZM

Trending

Name
Price
Price Change
SPX
S&P 500
―
DJIA
Dow Jones
―
NDX
Nasdaq 100
―
More Trending Stocks >